Moderna Inc MRNA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 04/16/21 EDT
170.80quote price arrow down-0.01 (-0.01%)
Volume
160,401
Close
170.81quote price arrow up+10.94 (+6.84%)
Volume
18,841,981
52 week range
33.72 - 189.26

...

Loading . . .
  • Open158.68
  • Day High171.92
  • Day Low158.21
  • Prev Close159.87
  • 52 Week High189.26
  • 52 Week High Date02/08/21
  • 52 Week Low33.72
  • 52 Week Low Date04/15/20

Key Stats

  • Market Cap68.355B
  • Shares Out400.18M
  • 10 Day Average Volume8.43M
  • Dividend-
  • Dividend Yield-
  • Beta1.4
  • YTD % Change63.5

KEY STATS

  • Open158.68
  • Day High171.92
  • Day Low158.21
  • Prev Close159.87
  • 52 Week High189.26
  • 52 Week High Date02/08/21
  • 52 Week Low33.72
  • 52 Week Low Date04/15/20
  • Market Cap68.355B
  • Shares Out400.18M
  • 10 Day Average Volume8.43M
  • Dividend-
  • Dividend Yield-
  • Beta1.4
  • YTD % Change63.5

RATIOS/PROFITABILITY

  • EPS (TTM)-1.94
  • P/E (TTM)-88.17
  • Fwd P/E (NTM)7.95
  • EBITDA (MRQ)-731.893M
  • ROE (MRQ)-39.99%
  • Revenue (MRQ)803.40M
  • Gross Margin (MRQ)70.05%
  • Net Margin (MRQ)-92.99%
  • Debt To Equity (MRQ)5.24%

EVENTS

  • Earnings Date05/05/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO0:3400:34
Moderna: Data shows Covid vaccine 90% effective after six months

Profile

MORE
Moderna, Inc. is engaged in transformative medicines based on messenger ribonucleic acid (mRNA). It has created a platform to improve the underlying pharmaceutical properties of our mRNA medicines. Its platform consists of three areas: mRNA technologies, delivery technologies, and manufacturing processes. It is pursuing mRNA science to minimize the undesirable activation of the immune system by mRNA and to maximize the potency of mRNA once in the target cells. It has advanced...
Noubar Afeyan Ph.D.
Non-Executive Chairman
Stephane Bancel
Chief Executive Officer
Stephen Hoge M.D.
President
David Meline
Chief Financial Officer
Juan Andres
Chief Technology Officer
Lori Henderson J.D.
General Counsel
Address
200 Technology Sq
Cambridge, MA
02139-3578
United States

Top Peers

SYMBOLLASTCHG%CHG
ILMN
Illumina Inc
399.00-2.96-0.74%
BNTX
BioNTech SE
151.54+10.82+7.69%
GMAB
Genmab A/S
35.23+0.25+0.71%
SGEN
Seagen Inc
145.50-4.14-2.77%
EXAS
Exact Sciences Corp
130.04-0.48-0.37%